133 related articles for article (PubMed ID: 12821588)
1. Hippocrates revisited: the evidence for drug-eluting stents.
Kereiakes DJ
Circulation; 2003 Jun; 107(24):3012-4. PubMed ID: 12821588
[No Abstract] [Full Text] [Related]
2. Drug-eluting stents: costs versus clinical benefit.
O'Neill WW; Leon MB
Circulation; 2003 Jun; 107(24):3008-11. PubMed ID: 12821587
[No Abstract] [Full Text] [Related]
3. Drug-eluting stents: cost versus clinical benefit.
Lemos PA; Serruys PW; Sousa JE
Circulation; 2003 Jun; 107(24):3003-7. PubMed ID: 12821586
[No Abstract] [Full Text] [Related]
4. Drug eluting stents: maximising benefit and minimising cost.
Gunn J; Morton AC; Wales C; Newman CM; Crossman DC; Cumberland DC
Heart; 2003 Feb; 89(2):127-31. PubMed ID: 12527654
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents: new era and new concerns.
Bhatia V; Bhatia R; Dhindsa M
Postgrad Med J; 2004 Jan; 80(939):13-8. PubMed ID: 14760171
[TBL] [Abstract][Full Text] [Related]
6. Are drug eluting stents really worth the money?
Thomas M
Heart; 2006 Jan; 92(1):5-7. PubMed ID: 15939723
[TBL] [Abstract][Full Text] [Related]
7. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.
Waksman R; Weinberger J
Circulation; 2003 Jul; 108(4):386-8. PubMed ID: 12885731
[No Abstract] [Full Text] [Related]
8. Vascular brachytherapy boon or bust?
Kereiakes DJ; Willerson JT
Circulation; 2003 Jul; 108(4):389-90. PubMed ID: 12885732
[No Abstract] [Full Text] [Related]
9. Systemic drug therapy for restenosis: "déjà vu all over again".
Faxon DP
Circulation; 2002 Oct; 106(18):2296-8. PubMed ID: 12403655
[No Abstract] [Full Text] [Related]
10. Vascular radiation in a drug-eluting stent world: it's not over till it's over.
Teirstein PS; King S
Circulation; 2003 Jul; 108(4):384-5. PubMed ID: 12885730
[No Abstract] [Full Text] [Related]
11. From randomized trials to routine clinical practice: an evidence-based approach for the use of drug-eluting stents.
Thanigaraj S; Wollmuth JR; Zajarias A; Chemmalakuzhy J; Lasala JM
Coron Artery Dis; 2006 Dec; 17(8):673-9. PubMed ID: 17119375
[TBL] [Abstract][Full Text] [Related]
12. Critical role of bare-metal stent controls in trials of drug-eluting stents.
Biondi-Zoccai GG; Agostoni P; Abbate A; Airoldi F; Colombo A
Eur Heart J; 2005 Aug; 26(16):1686-7; author reply 1687. PubMed ID: 15946954
[No Abstract] [Full Text] [Related]
13. Economics of sirolimus-eluting stents: drug-eluting stents have really arrived.
Weintraub WS
Circulation; 2004 Aug; 110(5):472-4. PubMed ID: 15289386
[No Abstract] [Full Text] [Related]
14. [Benefits and risks of drug-eluting stents].
Zijlstra F
Ned Tijdschr Geneeskd; 2007 May; 151(18):1005-7. PubMed ID: 17508683
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stents: the panacea for restenosis?
Lim MC
Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
[No Abstract] [Full Text] [Related]
16. Drug eluting stents: an updated meta-analysis of randomised controlled trials.
Roiron C; Sanchez P; Bouzamondo A; Lechat P; Montalescot G
Heart; 2006 May; 92(5):641-9. PubMed ID: 16216853
[TBL] [Abstract][Full Text] [Related]
17. [Drug-eluting stents: do they keep their promises?].
Nordmann A
Praxis (Bern 1994); 2006 Apr; 95(15):581-3. PubMed ID: 16640178
[No Abstract] [Full Text] [Related]
18. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials.
Mauri L; Orav EJ; Candia SC; Cutlip DE; Kuntz RE
Circulation; 2005 Nov; 112(18):2833-9. PubMed ID: 16267256
[TBL] [Abstract][Full Text] [Related]
19. [Antiproliferative drug-eluting stents: systematic review of the benefits and estimate of economic impact].
Oliva G; Espallargues M; Pons JM
Rev Esp Cardiol; 2004 Jul; 57(7):617-28. PubMed ID: 15274846
[TBL] [Abstract][Full Text] [Related]
20. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials.
Halkin A; Stone GW
J Interv Cardiol; 2004 Oct; 17(5):271-82. PubMed ID: 15491330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
